Clinical Trial Update: IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes testing belumosudil in combination with an IL-6 receptor inhibitor for belumosudil-refractory chronic graft-versus-hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Stanford University | Conditions: cGVHD | Phase 1 | Status: NOT_YET_RECRUITING